Le Lézard
Classified in: Health, Science and technology
Subjects: CCA, FVT

BioMarin to Host Fourth Quarter and Full-Year 2023 Financial Results Conference Call and Webcast on Thursday, February 22, 2024, at 4:30pm ET


SAN RAFAEL, Calif., Feb. 8, 2024 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President and Chief Executive Officer of BioMarin, will host a conference call and webcast on Thursday, February 22, at 4:30 p.m. ET to discuss fourth quarter and full-year 2023 financial results and provide a general business update.

Dial-in Number 
U.S. / Canada Dial-in Number: 888-330-3073
International Dial-in Number: 646-960-0683
Conference Call ID: 1816377

U.S. / Canada Replay Dial-in Number: 800-770-2030
International Replay Dial-in Number: 647-362-9199
Playback ID: 1816377

Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website, https://investors.biomarin.com/. A replay of the call will be archived on the site for one week following the call.

About BioMarin
Founded in 1997, BioMarin is a global biotechnology Company dedicated to transforming lives through genetic discovery. The Company develops and commercializes targeted therapies that address the root cause of the genetic conditions. BioMarin's unparalleled research and development capabilities have resulted in eight transformational commercial therapies for patients with rare genetic disorders. The Company's distinctive approach to drug discovery has produced a diverse pipeline of commercial, clinical, and pre-clinical candidates that address a significant unmet medical need, have well-understood biology, and provide an opportunity to be first-to-market or offer a substantial benefit over existing treatment options. For additional information, please visit www.biomarin.com.

Contacts:


Investors                                         

Media

Traci McCarty                                   

Marni Kottle

BioMarin Pharmaceutical Inc.    

BioMarin Pharmaceutical Inc.

(415) 455-7558                                 

(650) 374-2803

 

SOURCE BioMarin Pharmaceutical Inc.


These press releases may also interest you

at 09:00
Ceapro Inc. Reports 2023 Financial Results and Operational Highlights
? 2023 marked by Ceapro's achievement of key milestones and progress toward its next phase of growth ? R&D activities focused on advancement of avenanthramide Phase 1-2a clinical study and the processing of yeast beta glucan along with the...

at 09:00
Zefiro Registers its First Methane Reduction Project on American Carbon Registry
ZEFIRO METHANE CORP. (Cboe Canada: ZEFI) (the "Company", "Zefiro", or "ZEFI") is pleased to announce that it has successfully completed its first listing on American Carbon Registry ("ACR"). This listing has been "in the works" since approximately...

at 08:54
Shiji Enterprise Platform PMS is Selected by Melco Resorts & Entertainment to Power its Digital Transformation
Shiji, the global hospitality technology innovator, has announced that Melco Resorts & Entertainment (Melco), owner and operator of integrated resort facilities in Asia and Europe has selected Shiji Enterprise Platform PMS to power their global...

at 08:51
ArgoCTS: Your Go-To Local Cyber Security and Managed IT Service Provider in Tacoma, WA & Surrounding Areas
ArgoCTS, a leading provider of cybersecurity and managed IT services in Tacoma, WA, and surrounding areas, is proud to announce its continued commitment to delivering top-notch IT solutions to businesses of all sizes. With over two decades of...

at 08:50
Agilent Names Simon May to Lead Diagnostics and Genomics Group
Agilent Technologies, Inc. today announced Simon May has been named president of the company's Diagnostics and Genomics Group (DGG). May, previously executive vice president and president of the Life Science Group at Bio-Rad Laboratories, will join...

at 08:50
UPDATE- FreshBooks Launch FreshBooks Payments, Leveraging Stripe Connect's New and Innovative Technology
FreshBooks, a leader in cloud-based accounting software for small businesses and accountants, announces FreshBooks Payments. Starting this summer, FreshBooks customers can sign up for FreshBooks Payments, which leverages Stripe Connect's latest...

More news about Science and technology...


News published on and distributed by: